---
title: "Treatment of Tumor Lysis Syndrome"
date: "2023-02-08"
enableToc: false
---

> [!info]
>
> ğŸŒ±ä¾†è‡ª: [[Tumor Lysis Syndrome - Fast Facts]]

# Treatment of Tumor Lysis Syndrome

â€¢ Avoid IV contrast and NSAIDs; treat hyperK, hyperPO4, and only symptomatic hypoCa
â€¢ Allopurinol + aggressive IV hydration Â± diuretics to â†‘ UOP for goal 80â€“100 cc/h
â€¢ Rasburicase (0.1â€“0.2 mg/kg or 6 mg IV fixed dose) for â†‘â†‘ uric acid esp. in aggressive malig (JCO 2003;21:4402; Acta Haem 2006;115:35). Avoid in G6PD def (hemolytic anemia). Consider G6PD testing in Jehovahâ€™s Witnesses especially if Black (12% prevalence).
â€¢ Hemodialysis may be necessary; early renal consultation for renal insufficiency or ARF


*   consider intensive care unit (ICU) transfer, depending on clinical status and degree of metabolic derangement (**Note:** TLS implies a highly responsive tumor and initial response to therapy.)

*   lab tests every 4 to 6 hours and treatment of electrolyte abnormalities

*   cardiac monitoring

*   intravenous fluids (IVF)

*   rasburicase for significant hyperuricemia, particularly if renal dysfunction is a concern

*   dialysis as a last resort



The following flowchart is helpful for the initial assessment and management of TLS:

###### (Source: The Tumor Lysis Syndrome.Â N Engl J Med 2011.)

Figure: ![ğŸï¸](https://i.imgur.com/IRpBg3R.png)
